11:21 AM EDT, 07/08/2024 (MT Newswires) -- Jaguar Health ( JAGX ) unit Napo Pharmaceuticals said Monday it secured new patents from the European and Australian patent offices for its plant-based prescription drug crofelemer.

The European patent covers methods for treating short bowel syndrome, bile acid diarrhea, and diarrhea related to small intestine resection or gallbladder removal with an inhibitor of chloride-ion transport such as crofelemer.

The Australian patent covers methods of preventing and treating diarrhea associated with congenital diarrheal disorders using a proanthocyanidin polymer composition such as crofelemer, the company said.

Jaguar Health ( JAGX ) shares were more than 7% higher in recent trading.

Price: 3.88, Change: +0.29, Percent Change: +8.08